Stonepine Capital Management, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q2 2023$4,642,058
-28.4%
448,508
-36.1%
1.67%
-23.0%
Q1 2023$6,482,183
-44.0%
701,535
-46.2%
2.17%
-55.4%
Q4 2022$11,574,880
+23.7%
1,304,947
+16.1%
4.87%
+15.8%
Q3 2022$9,354,000
+2.8%
1,124,220
+1.2%
4.20%
-0.7%
Q2 2022$9,099,000
+288.5%
1,111,050
+313.3%
4.23%
+335.9%
Q1 2022$2,342,000268,8330.97%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders